Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA
RSS SUMMARY · AGGREGATED FROM CBS NEWS
There's a new safety concern about doctors prescribing one experimental weight loss treatment, retatrutide, that hasn't even been FDA approved yet. Adam Yamaguchi reports.
There's a new safety concern about doctors prescribing one experimental weight loss treatment, retatrutide, that hasn't even been FDA approved yet. Adam Yamaguchi reports.
There's a new safety concern about doctors prescribing one experimental weight loss treatment, retatrutide, that hasn't even been FDA approved yet. Adam Yamaguchi reports.
Continue Reading
The full story continues on CBS News.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CBS NEWS
World News
Pulte appointment as acting DNI could hold up FISA reauthorization
CBS NEWS·49m ago·3 min read
World News
Trump influence to be tested again in South Carolina GOP primary for governor
CBS NEWS·57m ago·3 min read
World News
Political strategists react to Trump walking out of NBC interview, break down Wisconsin House race
CBS NEWS·42m ago·3 min read
World News
Breaking down Iran and Israel’s flare-up as Trump insists peace talks are proceeding
CBS NEWS·2h ago·3 min read
Related
On this beat
Health
Jim Cramer says he can’t sell Eli Lilly despite its massive run up. Here’s why
CNBC·9h ago·3 min read
Health
Zealand Pharma Shares Slide After Boehringer Study Shows Obesity Shot’s Side Effects
TWSJ·14h ago·3 min read
Health
Weight loss drug maker sinks 25% after new safety data spooks investors
CNBC·16h ago·3 min read
Health
Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success
TWSJ·16h ago·3 min read
